Minutes after the ribbon was cut at the new location, customers were already queued out the door, waiting to place their orders, while both drive-thru lanes were bumper to bumper.

The companies followed the data with an announcement to cut the price of Praluent (alirocumab) for the high-risk patients who need it the most – a one-two combination aimed at knocking down ...